Trump Tariffs on Pharmaceuticals Could Spike Costs 100% for Common Meds, Including Entresto to Keytruda [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
tariffs stricken down by the Supreme Court — the Trump administration surprised the nation on Liberation Day's first anniversary by announcing new tariffs on many brand-name drugs manufactured outside of the United States. This is a move that could, in the short term, radically increase the prices of your medication. Trump's plan ? To levy a 100% tariff on pharmaceutical companies that manufacture drugs in foreign countries, rather than in America. It's a policy designed to reshape the pharmaceutical industry in the long-term by incentivizing American manufacturing and price concessions, with large drug companies being given 120 days (and smaller companies 180 days) to negotiate the construction of American-based pharmaceutical plants to avoid the tariffs, per CNBC . The companies would then have until January 2029 to complete the actual plants. Consider This: I Compared Prices Before and After Trump's Tariffs — Here's What Changed Check Out: How Middle-Class Earners Are Quietly
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Johnson & Johnson (JNJ) had its price target raised by Morgan Stanley from $262.00 to $267.00. They now have an "overweight" rating on the stock.MarketBeat
- Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of VisionBusiness Wire
- Johnson & Johnson PFA Launch Puts VARIPULSE Pro And Valuation In Focus [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- How Raw Sugar Living's CEO Is Fighting Inflation In The Beauty Aisle [Forbes]Forbes
JNJ
Earnings
- 1/21/26 - Beat
JNJ
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/18/26 - Form 13F-HR/A
- 3/18/26 - Form 13F-HR/A
- JNJ's page on the SEC website